Sandoz stock target raised as AlphaValue keeps Reduce rating
Published on 11/19/2026 at 11:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst raises target, keeps caution
- AlphaValue/Baader lifted its Sandoz price target while retaining a Reduce rating.
- The broker views biosimilars as the company's main long-term growth driver.
- The revised target reflects stronger earnings assumptions but also a demanding valuation backdrop.
On November 17, AlphaValue/Baader Europe raised its price target for Sandoz while retaining a Reduce rating, according to Finimize. The broker set the target at 89.9 Swiss francs after Sandoz upgraded its 2026 guidance.
Higher target, unchanged rating
The combination of a higher target and an unchanged negative rating signals a more constructive earnings view without a corresponding change in the broker's valuation stance. Finimize said AlphaValue/Baader also lifted its projected EBITDA growth rate to 6% from 5.5%.
The broker continues to identify biosimilars as the principal structural opportunity. These lower-cost versions of biologic medicines can gain share as branded products lose exclusivity, while their economics may support stronger margins than traditional generics. Sandoz has highlighted biosimilars as a core part of its growth strategy.
Valuation remains the constraint
AlphaValue/Baader's caution rests on the share-price rerating already achieved. Finimize reported that Sandoz had gained roughly 260% since its October 2023 listing, leaving less room for further upside unless operating performance continues to exceed elevated expectations.
For investors, the message is mixed. Improved assumptions for long-term profitability support a higher target, but the Reduce rating indicates that the broker does not see the revised outlook as sufficient to justify a more positive view at the current valuation. Future results, guidance and execution in the biosimilar portfolio remain important catalysts.
Sandoz stock traded at 88.45 euros on Lang & Schwarz at 11:34 CET on Thursday, November 19.
Sandoz stock facts
- Company: Sandoz Group AG
- ISIN: CH1243598427
- Ticker: SDZ.SW
- Lang & Schwarz price: 88.45 euros at 11:34 CET on November 19, 2026
The SMI is the relevant Swiss-market reference for Sandoz stock.
